Privitera S, Prody C A, Callahan J W, Hinek A
Division of Cardiovascular Research, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
J Biol Chem. 1998 Mar 13;273(11):6319-26. doi: 10.1074/jbc.273.11.6319.
Our previous studies showed immunological and functional similarities, as well as partial sequence homology, between the enzymatically inactive alternatively spliced variant of human beta-galactosidase (S-gal) and the 67-kDa elastin/laminin-binding protein (EBP) from sheep. To define the genetic origin of the EBP further, a full-length human S-gal cDNA clone was constructed and subjected to in vitro transcription/translation. The cDNA was also transfected into COS-1 cells and into the EBP-deficient smooth muscle cells (SMC) from sheep ductus arteriosus (DA). In vitro translation yielded an unglycosylated form of the S-gal protein, which immunoreacted with anti-beta-galactosidase antibodies and bound to elastin and laminin affinity columns. S-gal cDNA transfections into COS-1 and DA SMC increased expression of a 67-kDa protein that immunolocalized intracellularly and to the cell surface and, when extracted from the cells, bound to elastin. The S-gal-transfected cells displayed increased adherence to elastin-covered dishes, consistent with the cell surface distribution of the newly produced S-gal-encoded protein. Transfection of DA SMC additionally corrected their impaired elastic fiber assembly. These results conclusively identify the 67-kDa splice variant of beta-galactosidase as EBP.
我们之前的研究表明,人β-半乳糖苷酶(S-gal)的无酶活性可变剪接变体与绵羊的67 kDa弹性蛋白/层粘连蛋白结合蛋白(EBP)之间存在免疫学和功能上的相似性,以及部分序列同源性。为了进一步确定EBP的基因起源,构建了全长人S-gal cDNA克隆并进行体外转录/翻译。该cDNA还被转染到COS-1细胞和来自绵羊动脉导管(DA)的EBP缺陷型平滑肌细胞(SMC)中。体外翻译产生了一种未糖基化形式的S-gal蛋白,它能与抗β-半乳糖苷酶抗体发生免疫反应,并与弹性蛋白和层粘连蛋白亲和柱结合。将S-gal cDNA转染到COS-1细胞和DA SMC中,增加了一种67 kDa蛋白的表达,该蛋白在细胞内和细胞表面进行免疫定位,并且从细胞中提取时能与弹性蛋白结合。转染了S-gal的细胞对覆盖有弹性蛋白的培养皿的粘附性增加,这与新产生的S-gal编码蛋白的细胞表面分布一致。对DA SMC的转染还纠正了它们受损的弹性纤维组装。这些结果最终确定β-半乳糖苷酶的67 kDa剪接变体为EBP。